A simple one step synthesis of magnetic-optical dual functional ZIF-8 in a sodalite phase for magnetically guided targeting bioimaging and drug delivery.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37850350.
- Also identified by DOI 10.1039/d3sm01100c.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Functionalized metal-organic frameworks (MOFs) that integrate targeted tumor imaging and drug delivery are expected to significantly enhance the therapeutic efficacy of cancer. However, the complicated synthesis process has greatly limited their utilization in clinical application. Herein, a one-step simple method was used to construct novel multifunctional MOFs by co-loading doxorubicin (DOX) and Fe<sub>3</sub>O<sub>4</sub> into the ZIF-8 with sodalite topology. DOX serves as a fluorescence imaging reagent and an anticancer drug and Fe<sub>3</sub>O<sub>4</sub> is used as a magnetic resonance imaging and magnetic targeting anticancer reagent. The fabricated DOX/Fe<sub>3</sub>O<sub>4</sub>@ZIF-8 nanocomposite showed excellent fluorescence and magnetic resonance imaging performances in tumors. Moreover, DOX/Fe<sub>3</sub>O<sub>4</sub>@ZIF-8 can be accumulated in tumors <i>via</i> a magnetic targeting effect and tumor growth could be inhibited <i>in vivo</i> due to the release of DOX. Additionally, the apoptosis process of DOX/Fe<sub>3</sub>O<sub>4</sub>@ZIF-8 on HepG2 cells is well investigated. Overall, DOX/Fe<sub>3</sub>O<sub>4</sub>@ZIF-8 synthesized in simple one step can be used for simultaneous targeted bioimaging and cancer therapy.
Medical subject headings
- Antineoplastic Agents
- Metal-Organic Frameworks